MECOM antisense RNA 1 (MECOM-AS1)

MECOM antisense RNA 1 (MECOM-AS1) is a long non-coding RNA transcribed from the antisense strand at the MECOM locus on chromosome 3 in humans[1][5]. As an antisense RNA, its canonical function is to regulate the expression of the protein-coding MECOM gene, which encodes a transcriptional regulator (MDS1 and EVI1 complex locus) important in hematopoiesis and leukemogenesis[1][4][7]. While the specific functional characterization of MECOM-AS1 itself in disease or therapeutics is not well documented in current sources, antisense RNAs generally modulate their sense counterpart via transcriptional interference, RNA-RNA duplex formation leading to changes in mRNA stability or translation, or by directing chromatin-modifying complexes for epigenetic regulation[7]. There are no drugs, biomarkers, or safety concerns currently reported for this non-coding RNA, and its specific roles in pathology, if any, remain uncharacterized in the available literature. Notes on interpretation: - MECOM-AS1 is distinct from MECOM itself, which is a well-established oncogene and therapeutic target[2][4][6]. MECOM-AS1 is the non-coding antisense transcript, not a protein-coding gene or druggable target. - There is no evidence in current sources that MECOM-AS1 is an established therapeutic target, nor that it directly interacts with any drugs. - Disease mutation, drug, and biomarker data instead relate to the protein-coding MECOM locus, not its antisense RNA[4][6].

Other names

MECOM-AS1